Cadre Holdings, Inc. (CDRE) stock
CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 15/3015% above fair value
$33.42+0.34 (+1.03%)
Close on Nov 13, 2026Market cap $1.43BP/E 36.7Yield 1.14%
Cadre total assets
Total assets on the balance sheet at the end of each period.
Cadre's total assets was $922.69M at Sep 30, 2026. For fiscal 2025 it was $770.03M, up 18.0% from the year before. The highest annual figure on record is $770.03M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $770.03M | +18.0% |
| FY2024 | Dec 31, 2024 | $652.71M | +51.4% |
| FY2023 | Dec 31, 2023 | $431.18M | +10.0% |
| FY2022 | Dec 31, 2022 | $391.95M | +25.7% |
| FY2021 | Dec 31, 2021 | $311.80M | +10.1% |
| FY2020 | Dec 31, 2020 | $283.28M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $922.69M | +16.5% |
| Q2 FY2026 | Jun 30, 2026 | $917.30M | +15.5% |
| Q1 FY2026 | Mar 31, 2026 | $879.74M | +34.0% |
| Q4 FY2025 | Dec 31, 2025 | $770.03M | +18.0% |
| Q3 FY2025 | Sep 30, 2025 | $792.06M | +28.5% |
| Q2 FY2025 | Jun 30, 2025 | $794.44M | +28.0% |
| Q1 FY2025 | Mar 31, 2025 | $656.29M | +9.5% |
| Q4 FY2024 | Dec 31, 2024 | $652.71M | +51.4% |
| Q3 FY2024 | Sep 30, 2024 | $616.62M | +46.6% |
| Q2 FY2024 | Jun 30, 2024 | $620.63M | +55.2% |
| Q1 FY2024 | Mar 31, 2024 | $599.44M | +54.1% |
| Q4 FY2023 | Dec 31, 2023 | $431.18M | +10.0% |
| Q3 FY2023 | Sep 30, 2023 | $420.51M | +12.1% |
| Q2 FY2023 | Jun 30, 2023 | $399.92M | +8.2% |
| Q1 FY2023 | Mar 31, 2023 | $388.98M | +21.2% |
| Q4 FY2022 | Dec 31, 2022 | $391.95M | +25.7% |
| Q3 FY2022 | Sep 30, 2022 | $375.18M | +24.2% |
| Q2 FY2022 | Jun 30, 2022 | $369.48M | +30.4% |
| Q1 FY2022 | Mar 31, 2022 | $321.00M | – |
| Q4 FY2021 | Dec 31, 2021 | $311.80M | – |
| Q3 FY2021 | Sep 30, 2021 | $302.02M | – |
| Q4 FY2020 | Dec 31, 2020 | $283.28M | – |
See a number that looks wrong?